Travelers Companies Q3FY26 Results: EPS seen at $7.13, down from $8.14
- Travelers Companies Q3 earnings due Oct 16; EPS estimated at $7.13 vs $8.14 prior year
- Revenue consensus at $11.02 billion, down from $11.13 billion last year
- Roth Capital raised PT to $425 while Mizuho cut PT to $345
- Stock closed at $360.61 after a 0.1% dip on Wednesday
*this image is generated using AI for illustrative purposes only.
The Travelers Companies, Inc. is scheduled to release its third quarter earnings report before the opening bell on Friday, October 16.
Analysts project quarterly earnings of $7.13 per share, a decline from $8.14 per share in the year-ago period. The consensus estimate for quarterly revenue stands at $11.02 billion, compared to $11.13 billion reported last year. Shares closed at $360.61 on Wednesday, falling 0.1%.
Analyst Ratings and Price Targets
Recent updates from major financial institutions reflect mixed sentiment on valuation and outlook. While some firms raised price targets, others maintained neutral or underweight stances with minor adjustments.
| Firm | Analyst | Rating | Previous PT | New PT | Date |
|---|---|---|---|---|---|
| Mizuho | Yaron Kinar | Neutral | $348 | $345 | Oct 7, 2026 |
| Evercore ISI Group | David Motemaden | In-Line | $338 | $342 | Sept 21, 2026 |
| Roth Capital | Harry Fong | Buy | $345 | $425 | July 21, 2026 |
| Barclays | Alex Scott | Underweight | $295 | $318 | July 21, 2026 |
| Morgan Stanley | Bob Huang | Underweight | $290 | $330 | July 21, 2026 |
What the Numbers Show
The divergence in analyst actions highlights a split in market expectations. Roth Capital’s significant increase in price target from $345 to $425 contrasts sharply with Mizuho’s reduction from $348 to $345. Despite the projected year-over-year decline in EPS from $8.14 to $7.13, several firms raised their targets following the company's better-than-expected second-quarter results reported on July 17.
How might the projected 12% year-over-year decline in EPS influence Travelers' capital return strategy, such as share buybacks or dividend hikes, for the upcoming fiscal year?
What specific underwriting loss ratios or catastrophe claims data will be critical to watch in the Q3 report to determine if the divergence between bullish and bearish analyst price targets is justified?
Given the mixed analyst sentiment and recent price target adjustments, how sensitive is TRV's stock price likely to be to guidance revisions regarding commercial property insurance pricing trends?
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
